HYPORT Noninferior for GU, GI Toxicity in Prostate Cancer

WEDNESDAY, April 10, 2024-- For patients with prostate cancer, hypofractionated postprostatectomy radiotherapy (HYPORT) is noninferior to conventionally fractionated postprostatectomy radiotherapy (COPORT) in terms of gastrointestinal (GI) or...